Back to Journals » Infection and Drug Resistance » Volume 12
Original Research
Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
7,978 | Dovepress* | 7,422+ | 1,669 | 9,091 | |
PubMed Central* | 556 | 222 | 778 | ||
Totals | 7,978 | 1,891 | 9,869 | ||
*Since 1 April 2019 |
View citations on PubMed Central and Google Scholar